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Abstract
The ideal bone graft substitute should
have certain properties and there are many
studies dealing with mixture of polymethyl-
metacrilate (PMMA) and β-tricalci-
umphospate (β-TCP) presenting the best
characteristics of both. Scanning Electron
Microscopy (SEM), for ultra-structural
data, resulted a very reliable in vivo model
to better understand the bioactivity of a
cement and to properly evaluate its suitabil-
ity for a particular purpose. The present
study aims to further improve the knowl-
edge on osteointegration development,
using both parameters obtained with the
Environmental Scanning Electron
Microscopy (ESEM) and focused histologi-
cal examination. Two hybrid bone graft
substitute were designed among ceramic
and polymer-based bone graft substitutes.
Based on β-TCP granules sizes, they were
created with theoretical different osteocon-
ductive properties. An acrylic standard
cement was chosen as control. Cements
were implanted in twelve New Zealand
White (NZW) rabbits, which were sacri-
ficed at 1, 2, 3, 6, 9 and 12 months after
cement implantation. Histological samples
were prepared with an infiltration process
of LR white resin and then specimens were
studied by X-rays, histology and ESEM.
Comparing the resulting data, it was possi-
ble to follow osteointegration’s various
developments resulting from different sizes
of β-TCP granules. In this paper, we show
that this evaluation process, together with
ESEM, provides further important informa-
tion that allows to follow any osteointegra-
tion at every stage of develop.
Introduction
More than 500,000 bone grafting proce-
dures are performed yearly in the United
States, to fill bone defects in orthopaedic
surgery, neurosurgery and dentistry.1,2 Bone
graft is the second most common transplan-
tation tissue, with blood being by far the
commonest.3 Bone graft substitutes can
either replace autologous bone graft or
expand an existing amount of autologous
bone graft. Autologous bone remains the
gold standard for stimulating bone repair
and regeneration. However there are several
limitations, especially if there is massive
segmental bone loss or a very large cancel-
lous void.4 The ideal bone graft substitute
should be biocompatible, bioabsorbable,
osteoconductive, osteoinductive, structural-
ly similar to the bone, easy to use and cost
effective.5,6 There are many studies dealing
with mixture of polymethylmetacrilate
(PMMA) and β-tricalciumphospate (β-
TCP) and presenting the best bone graft
substitution characteristics of both.7-9 In
fact, β-TCPs are reabsorbed through cell-
mediated processes, including osteoclast
activity.10,11 As a consequence of this mech-
anism resembling bone remodelling, β-TCP
will not disappear until new bone is being
formed.12 Therefore by mixing PMMA and
β-TCP, a bone void filler can be created
with osteoconductive properties i.e. proper-
ties of bioactivity.13,14 In this case bioactivi-
ty, as the interaction between a biomaterial
and the surrounding tissue, describes the
influence of a material on bone forma-
tion.13,15-17 To better understand the bioactiv-
ity of a cement and to properly evaluate the
suitability of cements for a particular pur-
pose, Dall’Oca et al.13 have demonstrated
the usefulness of the ultrastructural data
obtained by Scanning Electron Microscopy
(SEM) and proposed a new procedure to
test the bioactivity of acrilic cements in vivo
models. This approach improves the visual-
ization of the bone-cement interface, adding
new data on the behavior of an important
component of treatment.13 Porous cements
made of β-TCP/PMMA could be considered
for vertebroplastic or augmentation
orthopaedics uses,14,18-20 but further studies
are necessary in order to evaluate the in vivo
properties of this material. The present
study aims to further improve the proposed
procedure, using parameters obtained with
the Environmental Scanning Electron
Microscopy (ESEM).
Materials and Methods
Bone cements
A hybrid bone graft substitute was
designed between ceramic and polymer-
based bone graft substitutes. It is made up
of a mixture of PMMA and β-TCP to be
osteoconductive, to facilitate osteointegra-
tion of the bone void filler. By mixing
PMMA with granules and powder of β-
TCP, bone void fillers with different osteo-
conductive properties were created. Pores
give bone the opportunity to grow in,
resulting in better fixation of the void filler
which remains implanted permanently. For
control group it was used a PMMA cement
without β-TCP(Mendec Spine® Tecres
SpA, Sommacampagna, VR, Italy),  named
C cement. For the experimental groups,
two cements presenting different character-
istics of porosity were realized, with the
purpose of studying the behavior of bone
tissue along the time. One using β-TCP in
powder (granules of 53 μg) named P
cement (Porosectan® I, Tecres SpA) and
the second one composed by β-TCP in
powder (granules of 53 μg) and granules
(100-300 μg), named PG cement
(Porosectan® II, Tecres SpA). The β-TCP
powder used in this cement meets the med-
ical grade standard described by ASTM
1088 4a (2010) Standard Specification for
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Beta-Tricalcium Phosphate for Surgical
Implantation. This was carefully chosen to
be aligned with available studies on pore
size.21 The specimens of the implanted
material, supplied by the Company Tecres
SpA, were made up of cylinders of 2 mm in
diameter and 6 mm in length; their compo-
sition is shown in Table 1. 
All experiments were performed
according to the following standards:
UNI EN ISO 10993-6:2007:  Test of local
effects after implantation;
UNI EN ISO 10993-1:2004: Biological
evaluation of medical devices. Part 1
Evaluations and testing;
UNI EN ISO 10993-12:2005: Sample and
reference materials.
Animals
Cements were implanted in twelve New
Zealand White (NZW) rabbits, which were
sacrificed at 1, 2, 3, 6, 9 and 12 months after
implantation of the cement. The animals
used were female rabbits weighting
between 3 and 4.5 kg before the beginning
of the study. The rabbits were reared and
operated at CIRSAL (Centro
Interdipartimentale per la Ricerca
Scientifica su Animali da Laboratorio -
Interdepartmental Center of Scientific
Research on Laboratory Animals,
University of Verona). Breeding conditions
were in accordance with the European
Directives (CE Directive 86/609) and UNI
EN ISO 10993-2; (2006): Animal welfare
requirement. They were bred in an individ-
ual metallic cage (Tecniplast® according to
D.Lgs 116/02) and fed with complete gran-
ular diet for rabbits, ad libitum. Water was
freely accessible. Temperature was between
15 to 21°C and room relative humidity was
between 30% to 70%. The operative staff
was qualified and educated. Experiments
were approved by Ethics Committee of
Verona University and performed in accor-
dance with the Guideline for Animal
Experimentation of the Italian Department
of Health, under the supervision of a veteri-
narian, and organized to minimize stress
and the number of rabbits used.
Surgery
After trichotomy of concerned area,
each rabbit was brought into operatory
room and positioned lateral on the operato-
ry table. General anesthesia induction was
carried out by a veterinarian with intramus-
cular injection of an association of tileta-
mine hydrochloride and zolazepam
hydrochloride (Zoletil 100®) at a dose of 20
mg/kg and Xylazione (Rompun®) at a dose
of 5 mg/kg. A local anesthesia with lido-
caine was also injected in the site of the sur-
gical incision.
After washing, disinfection and prepa-
ration of sterile operatory field, we made
small skin incisions on lateral surface of
both femur. The femur was drilled with ster-
ile electrical drill (diameter 2 mm, depth 6
mm), in femoral distal and proximal meta-
physis on the right femur and in proximal
metaphysis on the left one. After drilling,
we washed and cleaned the holes to remove
every bone fragments created. We filled the
femoral cavities with cement cylinders, in
particular P cement distally and PG cement
proximally in the right femur, C cement in
the proximal methaphysys of the left femur.
We did skin suture with not reabsorbable
spin Prolene® n. 3-0. After final disinfec-
tion, we made an elastic adhesive bandage.
Analgesic therapy with Altadol® IM (4
mg/Kg) was administrated to the rabbits,
after that the animals were located under
UV lamp for 10 min, before returns in their
cage.
Post-operative clinical follow-up and
animal sacrifice
Animals were observed daily to detect
clinical abnormalities and antibiotic therapy
was administrated for four days (Baytril®
2.5% SC 5 mg/Kg). Medications with
iodate antiseptic (Braunol®) were done, and
cutaneous stitches were removed 10 days
after surgery. The rabbits’ state of well-
being was assessed with physiological ele-
ments (feeding, stool and urine), physical
elements (functions of operated limb and
coat growth) and behavior elements, like
‘open field’. This test, known as ‘escape
test’, is an indication of fear response (rab-
bit is prey animal, with avoidance reactions,
like fear of new situations and human pres-
ence).
Rabbits were sacrificed through phar-
macology euthanasia with a lethal injection
of Tanax® after 1-2-3-6-9-12 months. Both
femurs were extracted from thigh, bone
curettage from soft tissues was carried out
and then all bones were put inside a trans-
parent sterile envelope.
Macroscopic and radiographic
examination, MRI observation
After the removal of the femurs, macro-
scopic observations and digital pictures of
the implant areas were performed. A radi-
ographic examination was carried out post
mortem using a Philips Practix 360 mobile
radiography system, to define the area of
samples: it consisted of antero-posterior and
lateral side of left and right femur of each
rabbit. 
Magnetic resonance imaging (MRI)
was acquired the using a Bruker BioSpec
tomograph for animals (4.7 T), equipped
with self-shielded gradients and BGA9
BGA20 (Bruker, Bremen, Germany). The
bones were positioned above the coil flat
surface and then into the magnet. T1w and
T2w sequences were acquired respectively
with techniques Spin Echo and RARE
(Rapid Acquisition with Relaxation
Enhancement). The acquisition and geomet-
ric parameters (number of virtual slices,
slice thickness, field of view, the matrix)
have been optimized for the bone tissue.
Histological samples preparation
The freshly explanted femurs were
cleaned from soft tissue and rinsed in saline
solution, then fixed in buffered formalde-
hyde (pH=7) for a minimum time of 20
days at 4°C. With reference to the analysis
of X-ray and MRI, it was possible to accu-
rately dissect the femur close to the cement
cylinders. Each section was progressively
dehydrated by immersion in increasing con-
centrations of ethanol (30%, 50%, 80%,
95%, 100%), leaving the sample steeped for
                             Technical Note
Table 1. Tested bone cements composition.
                                                       C cement                                                      P cement*                                         PG cement°
Cylinder composition               Polymethylmethacrylate 67.5%                                    Polymethylmethacrylate 52.9%                     Polymethylmethacrylate 40.7%
                                                             Barium sulphate# 30.0%                                          β-tricalcium phosphate§ 26.1%                    β-tricalcium phosphate§ 33.3%
                                                              Benzoyl peroxide 2.5%                                                 Barium sulphate^ 7.0%                     β-tricalcium phosphate granule$ 8.3%
                                                                                                                                                          Benzoyl peroxide 1.0%                                   Benzoyl peroxide 1.0%
                                                                                                                                                           Saline solution 13.0%                                      Saline solution 16.7%
*No granule of β-tricalcium phosphate, only powder; °with granule and powder of β-tricalcium phosphate; #barium sulphate powder; §β-tricalcium phosphate powder 53 micron; ^barium sulphate gran-
ule 200-400 micron; $β-tricalcium phosphate granule 100-300 micron.
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at least 48 h for each concentration, and per-
forming three passages in absolute ethanol.
The infiltration with LR white resin was
performed at room temperature with 3 pas-
sages, each of 72 h, in oxygen-poor envi-
ronment by placing the samples under vac-
uum (with glass bell) to promote the pene-
tration of the resins. Polymerization took
place by UV radiation at room temperature
for at least 3 days in oxygen-poor environ-
ment. Once cured, specimens were sec-
tioned with a diamond saw blade mounted
on a Leitz microtome according to a plane
perpendicular to the femur axis. For each
sample, sections were obtained with a thick-
ness of about 100 μm, then manually
thinned down to a thickness of 30 μm ±10
with fine abrasive paper (P paper water-
proof 1000 WSC BMA) immersed in cold
water at 4° C approximately to prevent sur-
face overheating. The obtained sections
were stained by immersion in a toluidine
blue 1% solution for 5 min, rinsed in run-
ning water, immersed in a 2% acid fuchsine-
solution for 3-5 min, rinsed in running
water, immersed in a 0.02% solution of
acetic acid for 1 minute, stained with fast
green (Diapath) for 5 min and finally rinsed.
The stained sections were put on slides
holders with aqueous upright and observed
under an optical microscope Olympus
BX51 both bright field and in fluorescence.
The digital images were acquired with high
resolution camera Quicam connected to
Dell PC using software image analysis
Imageproplus v.7 (MediaCybernetic,
Bethesda, MD, USA).
Evaluations of biocompatibility (local tol-
erance) and osteointegration
The local tolerance was evaluated
according to microscopic criteria. A semi-
quantitative analysis was defined in accor-
dance with the UNI EN ISO 10993-6:2009.
Particular attention was given to the inflam-
matory response, the behavior of the bone
and the nature of the contact bone/implant.
Each parameter was evaluated by scoring
from 0 (absent) to 4 (severe) allowing an
accurate assessment of the phenomena of
inflammation and/or foreign body reaction,
bone repair and degradation of the material.
The biocompatibility evaluation scale is
reported in Table 2. To evaluate the osteoin-
tegration of the cements, we defined a scale
of evidences according to the grading
described in Table 3.
Ultrastructural analysis
In order to obtain samples for the
investigation with the ESEM, longitudinal
cuts have been performed until the expo-
sure of the surfaces of the plants grafted. In
order to better understand the phenomenon
of osteointegration, we proceeded to the
observation with electron microscope
ESEM equipped with Energy Dispersive
Spectrometry (EDS) microanalytical
Probe. The combined use of ESEM with
EDS allows to provide the chemical com-
position of a point of interest on the sample
surface (microanalysis). The sections
obtained, with a thickness of about 2-3 mm,
were put on aluminum stubs with sticky
carbon and observed with the electron
microscope ESEM XL 30 FEI Philips low
vacuum equipped with EDAX® probe for
microanalysis.
Results
Post-operative clinical follow-up
The surgery procedure was well-tolerat-
ed and the animals managed to feed himself
since the day after the operation. Within a
few days, they managed to move again
inside the cage. Neither signs of local
swelling or inflammation, nor systemic
signs of cement-toxicity or allergic reac-
tions were found. All the animals subjected
to the operation survived.
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Table 2. Biocompatibility evaluation scale.
Cell reaction                                                                                               Definitions
Score                                                   0                                   1                                                             2                                                   3                                                  4
Flogosis                                         Absent                         Slight                                                 Moderate                                     Intense                                       Severe
Polymorphonuclear cells                0                       Rare, 1-5 / phf                                          5-10 / phf                           Intense infiltration                               Full
Lymphocytes                                      0                       Rare, 1-5 / phf                                          5-10 / phf                           Intense infiltration                               Full
Plasmacells                                        0                       Rare, 1-5 / phf                                          5-10 / phf                           Intense infiltration                               Full
Macrophages                                     0                       Rare, 1-5 / phf                                          5-10 / phf                           Intense infiltration                               Full
Giant cells                                          0                       Rare, 1-2 / phf                                           3-5 / phf                            Intense infiltration                           Laminae
Necrosis                                        Absent                      Minimum                                                 Slight                                       Moderate                                     Severe
Neovascularization                     Absent             Minimum capillary                         Groups of 4-7 capillary            Wide band of capillary                      Wide band
                                                                                vessels proliferation,                     vessels with fibroclastic                    vessels with                   of capillary vessels with
                                                                                        focal, 1-3 bud                                structure of support               fibroclastic structure             fibroclastic structure
                                                                                                                                                                                                                of support                                 of support
Fibrosis                                         Absent                     Thin band                                  Moderately thick band                       Thick band                                Thick band
Fat infiltration                              Absent                      Minimum                                       Several layers of                    Stretched and wide                 Wide accumulation
                                                                                        amount of fat                                     fat and fibrosis                     accumulation of fat                   of fat completely
                                                                                      associated with                                                                                cells around the implant         surrounds the implant
                                                                                             fibrosis                                                                                                                                                                 
Evaluation criteria           Score                                                                                                                         Irritation degree
                                           0.0 – 2.9                                                                                                                           Not irritating
                                           3.0 – 8.9                                                                                                                        Slightly irritating
                                            9.0 – 15                                                                                                                    Moderately irritating
                                               > 15                                                                                                                          Severely irritating
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Macroscopic and radiographic
examination, MRI observation
The visual appearance of implants had
three kinds of features: some with an evi-
dent trace of the plant (Figure 1A), some
with a bulge as a consequence of bone cal-
lus (Figure 1B) and others with an homoge-
neous surface where the implant was not
identifiable (Figure 1C). These different
visual appearances were detected in all
three types of cements and in every period
without any relationship between the
macroscopic and the microscopic findings.
Radiographic analysis (Figure 2)
showed a good adjustment and maintenance
of the samples in the original implant areas,
in all different times and for all three types
of cements. In the samples of the PG
cement, x-ray images showed a weaker sig-
nal compared to C and P cements. In partic-
ular, for PG cement the radiographic images
at 6 months do not show sufficiently the
implant. Because of that a more efficient
identification was carried out by magnetic
resonance imaging. With the MRI, the
implant of the PG cement at 6 months was
evident in its shape and position (Figure 3).
Newetheless, it was well visible at 12
months (Figure 2I).
Evaluations of biocompatibility (local
tolerance) and usteointegration
The results of the semi-quantitative
evaluation of local tolerance (biocompati-
bility) are reported in Table 4. In the early
times (1st month) at the periphery of the
implants the formation of a bony capsule of
variable thickness is visible. In these areas
there are aspects of cellular suffering of
modest degree, not significantly different
                             Technical Note
Table 3. Description of grading.
Grading                     Description
G0                                         No penetration of organic material inside the resin.
G1                                         Presence of organic material fuchsin positive into part of the sample
G2                                         Presence of organic material fuchsin positive in most of the sample
G3                                         Presence of cells in part of the sample
G4                                         Presence of cells in the majority of the sample
G5                                         Presence of osteoid formations within the sample
G6                                         Training osteonic spread over the whole sample
Table 4. Biocompatibility evaluation results.
Score
                                                    Month 1                   Month 2                 Month 3                Month 6               Month 9              Month 12
Cement                                                C          P           PG            C          P          PG            C       P       PG             C        P      PG             C       P      PG             C       P      PG
Flogosis                                               1          0            0              0          0           0              0        0        0               0         0        0               0        0        0               0       0       0
Polymorphonuclear cells                 0          0            0              0          0           0              0        0        0               0         0        0               0        0        0               0       0       0
Lymphocytes                                       0          0            0              0          0           0              0        0        0               0         0        0               0        0        0               0       0       0
Plasmacells                                         0          0            0              0          0           0              0        0        0               0         0        0               0        0        0               0       0       0
Macrophages                                      0          0            0              0          0           0              0        0        0               0         0        0               0        0        0               0       0       0
Giant cells                                           0          0            0              0          0           0              0        0        0               0         0        0               0        0        0               0       0       0
Necrosis                                              2          2            2              1          1           1              0        0        0               0         0        0               0        0        0               0       0       0
Neovascularization                            0          0            0              0          0           0              0        0        0               0         0        0               0        0        0               0       0       0
Fibrosis                                                2          2            2              1          2           2              2        2        2               2         2        2               2        2        2               2       2       2
Fat infiltration                                    0          0            0              0          0           0              0        0        0               0         0        0               0        0        0               0       0       0
Total score                                          5          4            4              2          3           3              2        2        2               2         2        2               2        2        2               2       2       2
Irritation degree                           Slight  Slight    Slight       Not   Slight   Slight       Not   Not    Not          Not    Not   Not           Not   Not    Not          Not   Not   Not
Figure 1. Macroscopic images of some femurs. Visual appearance of implants: evident
trace of the implant (A), bulges resulting in bone callus (B) and implant with external
homogenous surface (C). Scale bar: 1 cm.
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between the cements. These issues tend to
disappear in a longer time with bone reac-
tion thickening around the implant. None of
the cement resulted in necrotic or inflam-
matory reactions of relief. There were sig-
nificant differences between the materials
in terms of biocompatibility parameters on
histological survey.
In histological preparations, the bone
matrix is indicated by the presence of mate-
rial fuchsin positive (f+). Histological sam-
ples of C cements did not show the presence
of f+ material at any month neither in the
peripheral areas nor inside the implant as
shown in Figure 4 A,B,C.
Histological samples of P cement
showed the presence of f+ material in the
peripheral areas staring from 1st month
(Figure 4D). At the 2nd month we witnessed
the entry of f+ material inside the newly
formed cavities in the implant; in the fol-
lowing months, no further progress was
noticed and it remain constant until 12th
month (Figure 4 E,F).
Histological samples of PG cement at
the 1st month showed the presence of f+
material in the peripheral areas (Figure 5A).
From the second month, we observed a pro-
gressive diffusion of f+ material over the
whole sample. From the first 2 months on
we observed the generation of a pattern of
micro internal cavity which was rapidly
invaded by organic f+ material probable of
fibrinoid nature. At month 3, the cement PG
showed an initial deposit of bone matrix in
the peripheral portion of the sample, partic-
ularly in areas with a greater density of f+
material (Figure 5B). After 3 months it
highlights the appearance, inside the plant,
of cellular elongated elements of fibroblas-
toid morphology. In the following months,
these phenomena tend to spread from
peripheral areas to the entire system. At the
6th month, we observed the presence of
osteoid material on the entire sample
(Figure 5C, red arrows). In the built up larg-
er blocks, you had cellular elements within
gaps. The osteoid material forms within the
central areas of the sample in which the fib-
rillar f+ material was organized to form real
well cellulate connective areas (Figure 5C,
yellow arrows). After the sixth month, the
f+ material filled in the previous months, is
flooded by fibroblastoid cellular elements
likely of bone marrow origin. In fact, at the
periphery of the sample, anatomical conti-
nuity is sometimes visible between the
internal areas of connective and bone mar-
row itself (Figure 5C, blue arrow). At the
periphery of these connective areas, at the
interface with the polymer, may yet be visi-
ble a layer of acellular fibrillar f+ material.
In larger areas we witnessed the deposition
                                                                                                       Technical Note
Figure 2. X-rays: antero-posterior and lateral side of femurs of three treatments (C cement
in top row, P cement in middle row, PG cement in the bottom row) to 1 month (left col-
umn), 6 months (middle column) and 12 months (right column). Radiographs showed
good images and maintenance of the samples in the original implant areas (red circles) in
all different times and for all three types of cements. Only the radiographic images of PG
cement at 6 months do not show sufficiently the implant (image H). Scale bar: 1 cm.
Figure 3. MRI of PG cement at 6 months. The implant is clearly visible in its shape and
position (red arrow).
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of bone matrix that presents isolated steps
of not osteocytic gaps, and others that are
organized into osteons. These areas may
have a diameter <300 μm (Figure 8A, 8B,
red circles). At the 9th month, the process of
cavitation in the sample is very large as well
as the deposition of bone matrix within the
space. Indeed, also aspects of bone deposi-
tion are visible in the central portions of the
sample (Figure 5D, red arrows). At the 12th
month, the process of formation of bone
material shall be borne by the connective
interior spaces that appear in almost all sites
of deposition of calcified matrix. The newly
formed areas assume a morphology with
osteoid formation of gaps and drafts of cel-
lular osteons-like systems (Figure 5E, red
arrows).
Results about osteointegration are
reported in Figure 6. In the C cement the
score was 0 at each time, showing a lack of
penetration of the organic material within
the polymer. The phenomena of osteointe-
gration appears in this case due to events
involving the external interface of the poly-
mer with the tissues and bone marrow. In
this regard, it was noted that the stability of
the sample did not significantly alter its
characteristics even in the observations car-
ried out up to 12th month. P cement had
score 1 at 1st month and score 2 at 2nd
month, which remained the same till the end
of the trial. The material belonging to the
group P is able to generate a lattice instead
of the internal micro-cavity that spreads
rapidly in the whole polymer during the
first two months. This lattice is rapidly
invaded by organic f+ material probable of
fibrinoid nature. It was noted that also in
this case the remarkable stability of the pat-
tern that does not appear to change signifi-
cantly up to 12th month.
PG cement increased progressively its
score from 1/2 of the 1st month up to 5 of the
12th month showing the best results between
the cements. PG cement has instead shown
a consistent and progressive increase of the
phenomena of osteointegration.
Ultrastructural analysis of cement
with ESEM 
At ESEM investigation before the
implant, C cement’s surface morphology
shows a rare presence of pores. There is no
substantial difference of the surface mor-
phology in the samples of the C cement
group from the first to the last month.  It is
characterized by large circular areas sur-
rounded by widespread granular deposition.
Throughout the whole samples sequence
(from 1st to 12th month) there are not evi-
dences of formation of bone matrix. The
microanalysis results are similar to the resin
                             Technical Note
Figure 4. Histological samples of C cement (A,B,C) and P cement (D,E,F), at 1st (A,D),
6th (B, E) and 12th month (C,F).  f+ material is visible at peripheral areas of the implant
(red arrows). Scale bars: 500 µm.
Figure 5. Histological samples of PG cement at 1st (A), 3rd (B), 6th (C), 9th (D) and 12th
month (E). f+ material is visible at peripheral areas of the implant (red arrows). Scale bars:
500 µm.
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before the implant (Figure 7 A,B). Circular
areas show main peaks attributable to car-
bon (C) and oxygen (O). The surrounding
surfaces with granular deposition have
highlighted peaks attributable to sulfur (S)
and barium (Ba). 
The surface morphology in the sample
of P cement shows a widespread presence
of 100 µm pores. From the 2nd to the 6th
month, morphological analysis of P cement
samples highlight some areas, inside the
material, with irregular formations of
deposits of granular appearance. They
match with the areas weakly f+ at the histo-
logical survey. In these areas the micro ana-
lytical survey detects high peaks due to cal-
cium (Ca) and phosphorus (P); the neigh-
bouring area showed only peaks attributable
to C and O due to the resin. On the 9th and
12th month P cement shows irregular areas
with granular appearance but with low den-
sity of granules inside (Figure 8 A,B). The
microanalysis shows significant peaks of
Ca and P (Figure 8C). There were no rele-
vant aspect of areas with sketches of
osteons. 
                                                                                                       Technical Note
Figure 6. Comparison of osteintegration grading at 1, 2, 3, 6, 9 and 12 months. The
horizontal axis shows the time, on the ordinate the osteointegration grading.
Figure 7. C cement, ESEM microscopy of C cement cylinder before the implant (A) and at 12 months (B). The microanalysis of the
sample before the implant end after 12 months shows similar peaks of C, O, S and Ba. Scale bars: A) 50 µm; B) 50 µm.
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The surface morphology in the sample
of PG cement shows a widespread presence
of 200-300 µm pores. Morphological analy-
sis of PG cement inside the cylinder at 1st
and 2nd month, highlighted several areas
with deposits of granular appearance
(Figure 9 A,B). These areas match with
weakly f+ areas of histological survey. On
these areas, microanalysis detected high
peaks attributable to Ca and P. The neigh-
boring areas showed peaks attributable to C
and O because of its resin composition. At
the 3rd month PG cement, in addition to the
various areas of granular appearance, fur-
ther areas begin to appear with the look of
sketches of osteons (Figure 9C). These
areas match with the fast green+ areas of
histological survey. On all these areas,
microanalytical probe detects high peaks
attributable to P and Ca. Otherwise, the sur-
rounding area showed only peaks attributa-
ble to C and O. At the 6th month, in PG
cement we observed a decrease of the gran-
ular looking areas and larger number of
areas of a clearer osteoid form (Figures 9D
and 10 A,B). On these areas microanalytical
probe detected high peaks attributable to Ca
and P (Figure 10 g,o). At 9th and 12th month,
in PG cement the areas with osteoid looking
sketches appear to be more widespread than
the granular areas which are significantly
reduced. They correspond to the fast green +
areas of histological survey. Such aspects
are not found in adjacent areas, consist of
resin alone.
Discussion
Histological analysis showed good
osteointegration of the samples. The
osteointegration was mediated by the for-
mation of a bone layer of variable thickness
on the boundary of the implant. This area
has no inflammatory or degenerative
aspects but the newly formed tissue and
appears constantly on the outside of the
implanted material. Apart from this feature,
we observed significant differences
between the three cements. C cement has
not occurred to any significant penetration
of the tissues inside of the resin at any
times.  The others cements had significant
phenomena of osteointegration not limited
to the outer surface but extended within the
implant. For both cements these phenomena
were characterized by the penetration of a
cellular matrix (f+) in the first two months
of implantation. While for the P cement
there have been no further developments in
later times, it appears to further progress in
PG cement only. In PG cement, from the
third month, we witnessed a gradual onset
                             Technical Note
Figure 8. P cement, optical (A) and ESEM (B) microscopy at 12 months. The microanaly-
sis of the sample (C) shows peaks of C, O, and significant peaks of P and Ca. Scale bars:
A) 200 µm; B) 100 µm.
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of cellular elements. We saw the appearance
of elongated cellular elements of fibroblas-
toid morphology, inside the internal cavities
of the implant. In the following months
there is an evolution of phenomena that
tend to spread from peripheral areas to the
entire system. The newly formed areas pro-
gressively assume a morphology with
osteoid formation of gaps and drafts of cel-
lular osteonic-like systems. By ESEM and
microanalysis we could closely follow the
evolution of the three cements within a
whole year of trial. As expected, in the sam-
ples of C cement from the first to the last
month (1-12), we did not observe a substan-
tial difference of the surface morphology of
the cylinder, characterized by large circular
areas surrounded by areas with the presence
of a widespread granular deposition. The
microanalysis on the circular areas, per-
formed in all periods, showed the main
peaks attributable C and O, due to the
TMMA composition and it was very similar
to the microanalysis of the cylinder before
the implantation. Differently, samples per-
formed in the P cement, from the 2nd to the
12th month, show a substantial uniformity of
diffusion of C and O peaks except small
scattered fragments attributable to Ca and P.
On 9th and 12th month, P cement showed
irregular areas with granular appearance
which presented significant peaks of Ca and
P. However, they did not form any osteoid
structure. The mapping with microanalysis
of PG cement have revealed and made even
more explicit the different chemical nature
and morphology of the areas analyzed.
From the 1st month inside the implant pro-
gressively increased several deposits of tri-
calcium phospate with high peaks attributa-
ble to Ca and P. At the 3rd month begin to
appear sketches of osteons which become
of a clearer osteoid form and greatly
increase the number in the following
months, replacing the granular areas. These
areas were phased out by growths of bone.
Because of this development PG cement,
consisting of acrylic resin-based porous
polymethacrylate and tricalcium phosphate
has characteristics of particular interest in
the process of osteointegration; especially
as regards the deposition of calcified matrix
within the polymer. Besides the different of
barium sulphate content, the main differ-
ence between P and PG consists of the size
of the granules21,23 (granules of 53 μm only
for P cement and also granules of 100-300
μm for PG cement) and pores (pores of
about 100 μm for P cement  and 100-200
μm for PG cement),  we can assume that P
cement not evolved in bone tissue inside the
implant in the following months probably
for the inability of the internal lattice to cre-
ate the environmental conditions able to
allow the evolution to the next generation of
true tissue areas within the polymer.
                                                                                                       Technical Note
Figure 9. PG cement, ESEM microscopy at 1, 2, 3, 6, 9, 12 months (panels A, B, C, D, E and F, respectively). The areas identified by the letters
‘g’ indicate the formation of granular appearance while those identified with letters ‘o’ indicate the osteoid formations. Scale bars: 100 µm.
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Hypothetically, we might assume that this
non-vascular and cellular invasion is due to
mechanical phenomena (pore size with
insufficient access as consequence of
using), rather than toxic factors, since there
were no cytotoxic aspects linked to the
polymer in the interface with the tissues of
the host bone marrow. Granules of 100-300
μm and pores of 100-200 μm allow the pen-
etrations of cells from the surrounding tis-
sue creating a tridimensional scaffold that
supply fluid penetration inside the matrix17
as demonstrated in vitro23 and in vivo13 stud-
ies.  In a previous work of Dall’Oca et al.13
it was shown the importance of the use of
LR white resin and the use of SEM to make
complete and objective assessment of the
biocompatibility of porous vs non porous
bone cements. In this paper, we show that
this evaluation process, together with the
microanalysis, provides further important
information that allows to follow any
osteointegration at every stage of develop.
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